Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen‐producing cells in systemic sclerosis fibroblasts
Open Access
- 1 August 1996
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 39 (8) , 1338-1346
- https://doi.org/10.1002/art.1780390811
Abstract
Objective. The goal of this study was to quantitatively analyze the distribution of collagen synthesis in normal and systemic sclerosis (SSc) fibroblast populations in order to determine the extent of activation in SSc populations.Methods. We used quantitative in situ hybridization to assess the population distribution of type I collagen synthesis. Fibroblast cultures were derived from both clinically involved and uninvolved skin regions of patients with SSc, and from healthy adults, and assessed for levels of α1(I) procollagen messenger RNA (mRNA).Results. Dermal fibroblasts from both patients with SSc and normal adults were heterogeneous for distribution of α1(I) procollagen mRNA when assessed by in situ hybridization, with a wide range of grains per cell. In contrast, clones of neonatal fibroblasts showed a relatively homogeneous distribution of grain counts. Involved SSc skin fibroblasts had a larger proportion of cells in the high collagen‐producing mRNA subpopulation (mean ± SEM 28.4 ± 6.85%), compared with normal fibroblasts (1.75 ± 1.44%) and uninvolved fibroblasts (9.6 ± 6.73%). Conversely, within the low collagen‐producing mRNA subpopulation, involved fibroblasts had a smaller proportion of cells (mean ± SEM 14.0 ± 5.63%) than did uninvolved fibroblasts (37.8 ± 13.69%), while normal fibroblasts had a majority of the cells in this subpopulation (53.5 ± 8.68%).Conclusion. These results suggest that only a specific subset of fibroblasts are activated in SSc, as evidenced by an increased proportion of cells with high levels of α1(I) procollagen mRNA. Differences between the SSc and normal fibroblast populations appeared to be quantitative rather than qualitative. This may be a result of either clonal selection or selective activation in the pathogenesis of SSc.Keywords
This publication has 28 references indexed in Scilit:
- Increased collagen synthesis in skin fibroblasts from patients with primary hypertrophic osteoarthropathy. evidence for trans–activational regulation of collagen transcriptionArthritis & Rheumatism, 1994
- Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis.Journal of Clinical Investigation, 1990
- Evaluation of Transforming Growth Factor β and Type I Procollagen Gene Expression in Fibrotic Skin Disease by In Situ HybridizationJournal of Investigative Dermatology, 1990
- Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts.Journal of Clinical Investigation, 1990
- Heterogeneous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissuesArthritis & Rheumatism, 1988
- Localization of collagen mRNA in normal and scleroderma skin by in‐situ hybridizationEuropean Journal of Clinical Investigation, 1988
- Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell products.Journal of Clinical Investigation, 1983
- Variability in Collagen and Fibronectin Synthesis by Scleroderma Fibroblasts in Primary CultureJournal of Investigative Dermatology, 1981
- Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production.Journal of Clinical Investigation, 1980
- Connective tissue synthesis by cultured scleroderma fibroblasts. I. In vitro collagen synthesis by normal and scleroderma dermal fibroblastsArthritis & Rheumatism, 1976